{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:28:12Z","timestamp":1792790892162,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Department of Science and Technology of Jilin Province","award":["20210101439JC"],"award-info":[{"award-number":["20210101439JC"]}]},{"name":"the Department of Science and Technology of Jilin Province","award":["20210303001SF"],"award-info":[{"award-number":["20210303001SF"]}]},{"name":"the first hospital of jilin university","award":["JDYYCB-2023010"],"award-info":[{"award-number":["JDYYCB-2023010"]}],"id":[{"id":"https:\/\/ror.org\/034haf133","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the first hospital of jilin university","award":["JDYYZH-2102030"],"award-info":[{"award-number":["JDYYZH-2102030"]}],"id":[{"id":"https:\/\/ror.org\/034haf133","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81970687"],"award-info":[{"award-number":["81970687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The clinical characteristics of Cushing\u2019s syndrome (CS) vary with etiology, and few studies have investigated the risk factors affecting CS recurrence after surgery. This retrospective study involved 202 patients diagnosed with CS between December 2012 and December 2022. The patients were divided into three groups according to etiology: Cushing's disease (CD), adrenocortical adenoma (ACA), and ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS). Of the patients with CS, 41.9% had hypokalemia and 15.0% had hypophosphatemia. The cortisol levels were negatively correlated with blood potassium, blood chlorine, and blood phosphorus. Moreover, 22.4% of patients had an abnormal heart structure, 11.2% had centripetal remodeling, 5.6% had centripetal hypertrophy, and 5.6% had centrifugal hypertrophy. The overall recurrence rate of CS caused by pituitary tumors and adrenal adenoma was 25.7%. The recurrence times were longer in the ACA group versus the CD group, in patients\u2009&lt;\u200950\u00a0years of age versus in patients\u2009\u2265\u200950\u00a0years old group, and in patients with CD with tumors\u2009\u2265\u20091\u00a0cm versus tumors\u2009&lt;\u20091\u00a0cm. Age, preoperative cortisol level, postoperative cortisol level, and absolute neutrophil value were closely related to postoperative recurrence, and etiology was an independent predictor of tumor recurrence in patients with CS. The results of this study showed that CS caused by different etiologies showed different clinical manifestations, blood electrolyte characteristics, and that CS could affect patient cardiac structure and function. Etiology is an independent predictor of tumor recurrence in patients with CS.<\/jats:p>","DOI":"10.1038\/s41598-024-53913-4","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T11:03:06Z","timestamp":1708945386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical features and risk factors for postoperative recurrence in patients with Cushing's syndrome of different etiologies"],"prefix":"10.1038","volume":"14","author":[{"given":"Yunjia","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Gang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"53913_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1530\/eje-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"Valassi, E. et al. The European Registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur. J. Endocrinol. 165, 383\u2013392. https:\/\/doi.org\/10.1530\/eje-11-0272 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"53913_CR2","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1530\/eje-16-0967","volume":"176","author":"E Valassi","year":"2017","unstructured":"Valassi, E. et al. Diagnostic tests for Cushing\u2019s syndrome differ from published guidelines: Data from ERCUSYN. Eur. J. Endocrinol. 176, 613\u2013624. https:\/\/doi.org\/10.1530\/eje-16-0967 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"53913_CR3","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1210\/jc.2007-2734","volume":"93","author":"BM Biller","year":"2008","unstructured":"Biller, B. M. et al. Treatment of adrenocorticotropin-dependent Cushing\u2019s syndrome: A consensus statement. J. Clin. Endocrinol. Metab. 93, 2454\u20132462. https:\/\/doi.org\/10.1210\/jc.2007-2734 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR4","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/s0140-6736(06)68699-6","volume":"367","author":"J Newell-Price","year":"2006","unstructured":"Newell-Price, J., Bertagna, X., Grossman, A. B. & Nieman, L. K. Cushing\u2019s syndrome. Lancet 367, 1605\u20131617. https:\/\/doi.org\/10.1016\/s0140-6736(06)68699-6 (2006).","journal-title":"Lancet"},{"key":"53913_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/s2213-8587(16)00086-3","volume":"4","author":"R Pivonello","year":"2016","unstructured":"Pivonello, R. et al. Complications of Cushing\u2019s syndrome: State of the art. Lancet Diabetes Endocrinol. 4, 611\u2013629. https:\/\/doi.org\/10.1016\/s2213-8587(16)00086-3 (2016).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"53913_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/nyas.14205","volume":"1463","author":"L Fan","year":"2020","unstructured":"Fan, L. et al. Association of hypokalemia with cortisol and ACTH levels in Cushing\u2019s disease. Ann. N. Y. Acad. Sci. 1463, 60\u201366. https:\/\/doi.org\/10.1111\/nyas.14205 (2020).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"53913_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.733793","volume":"12","author":"A Bosman","year":"2021","unstructured":"Bosman, A., van den Beld, A. W., Feelders, R. A. & Zillikens, M. C. Cortisol and phosphate homeostasis: Cushing\u2019s syndrome is associated with reversible hypophosphatemia. Front. Endocrinol. 12, 733793. https:\/\/doi.org\/10.3389\/fendo.2021.733793 (2021).","journal-title":"Front. Endocrinol."},{"key":"53913_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1365-2265.2011.04206.x","volume":"76","author":"PM Toja","year":"2012","unstructured":"Toja, P. M. et al. Clinical relevance of cardiac structure and function abnormalities in patients with Cushing\u2019s syndrome before and after cure. Clin. Endocrinol. 76, 332\u2013338. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04206.x (2012).","journal-title":"Clin. Endocrinol."},{"key":"53913_CR9","doi-asserted-by":"publisher","first-page":"E2144","DOI":"10.1210\/jc.2014-1783","volume":"99","author":"P Kamenick\u00fd","year":"2014","unstructured":"Kamenick\u00fd, P. et al. Cardiac structure and function in Cushing\u2019s syndrome: A cardiac magnetic resonance imaging study. J. Clin. Endocrinol. Metab. 99, E2144-2153. https:\/\/doi.org\/10.1210\/jc.2014-1783 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR10","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1210\/jc.2002-021494","volume":"88","author":"A Faggiano","year":"2003","unstructured":"Faggiano, A. et al. Nephrolithiasis in Cushing\u2019s disease: Prevalence, etiopathogenesis, and modification after disease cure. J. Clin. Endocrinol. Metab. 88, 2076\u20132080. https:\/\/doi.org\/10.1210\/jc.2002-021494 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR11","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1210\/jc.2002-021518","volume":"88","author":"F Pecori Giraldi","year":"2003","unstructured":"Pecori Giraldi, F., Moro, M. & Cavagnini, F. Gender-related differences in the presentation and course of Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 88, 1554\u20131558. https:\/\/doi.org\/10.1210\/jc.2002-021518 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR12","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1016\/s0140-6736(23)01961-x","volume":"402","author":"M Gadelha","year":"2023","unstructured":"Gadelha, M., Gatto, F., Wildemberg, L. E. & Fleseriu, M. Cushing\u2019s syndrome. Lancet 402, 2237\u20132252. https:\/\/doi.org\/10.1016\/s0140-6736(23)01961-x (2023).","journal-title":"Lancet"},{"key":"53913_CR13","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1210\/jc.2012-3582","volume":"98","author":"OM Dekkers","year":"2013","unstructured":"Dekkers, O. M. et al. Multisystem morbidity and mortality in Cushing\u2019s syndrome: A cohort study. J. Clin. Endocrinol. Metab. 98, 2277\u20132284. https:\/\/doi.org\/10.1210\/jc.2012-3582 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fendo.2019.00321","volume":"10","author":"M Barbot","year":"2019","unstructured":"Barbot, M., Ceccato, F. & Scaroni, C. The pathophysiology and treatment of hypertension in patients with Cushing\u2019s syndrome. Front. Endocrinol. 10, 321. https:\/\/doi.org\/10.3389\/fendo.2019.00321 (2019).","journal-title":"Front. Endocrinol."},{"key":"53913_CR15","doi-asserted-by":"publisher","first-page":"101380","DOI":"10.1016\/j.beem.2020.101380","volume":"34","author":"M Barbot","year":"2020","unstructured":"Barbot, M., Zilio, M. & Scaroni, C. Cushing\u2019s syndrome: Overview of clinical presentation, diagnostic tools and complications. Best Pract. Res. Clin. Endocrinol. Metab. 34, 101380. https:\/\/doi.org\/10.1016\/j.beem.2020.101380 (2020).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"53913_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2023.12.003","author":"O Ragnarsson","year":"2023","unstructured":"Ragnarsson, O., Juhlin, C. C., Torpy, D. J. & Falhammar, H. A clinical perspective on ectopic Cushing\u2019s syndrome. Trends Endocrinol. Metab. https:\/\/doi.org\/10.1016\/j.tem.2023.12.003 (2023).","journal-title":"Trends Endocrinol. Metab."},{"key":"53913_CR17","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1210\/jc.2004-2527","volume":"90","author":"I Ilias","year":"2005","unstructured":"Ilias, I. et al. Cushing\u2019s syndrome due to ectopic corticotropin secretion: Twenty years\u2019 experience at the National Institutes of Health. J. Clin. Endocrinol. Metab. 90, 4955\u20134962. https:\/\/doi.org\/10.1210\/jc.2004-2527 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2023.102898","volume":"54","author":"C Ramirez-Renteria","year":"2023","unstructured":"Ramirez-Renteria, C. Ectopic hormonal syndromes: Cushing\u2019s syndrome and acromegaly. Arch. Med. Res. 54, 102898. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102898 (2023).","journal-title":"Arch. Med. Res."},{"key":"53913_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1210\/jcem-70-1-200","volume":"70","author":"S Ulick","year":"1990","unstructured":"Ulick, S., Tedde, R. & Mantero, F. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 70, 200\u2013206. https:\/\/doi.org\/10.1210\/jcem-70-1-200 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1136\/jclinpath-2018-205130","volume":"72","author":"J Leung","year":"2019","unstructured":"Leung, J. & Crook, M. Disorders of phosphate metabolism. J. Clin. Pathol. 72, 741\u2013747. https:\/\/doi.org\/10.1136\/jclinpath-2018-205130 (2019).","journal-title":"J. Clin. Pathol."},{"key":"53913_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00223-011-9527-8","volume":"89","author":"I Ramon","year":"2011","unstructured":"Ramon, I., Kleynen, P., Valsamis, J., Body, J. J. & Karmali, R. Hypophosphatemia related to paraneoplastic Cushing syndrome in prostate cancer: Cure after bilateral adrenalectomy. Calcif. Tissue Int. 89, 442\u2013445. https:\/\/doi.org\/10.1007\/s00223-011-9527-8 (2011).","journal-title":"Calcif. Tissue Int."},{"key":"53913_CR22","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","volume":"42","author":"I Endo","year":"2008","unstructured":"Endo, I. et al. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: Proposal of diagnostic criteria using FGF23 measurement. Bone 42, 1235\u20131239. https:\/\/doi.org\/10.1016\/j.bone.2008.02.014 (2008).","journal-title":"Bone"},{"key":"53913_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jacc.2015.10.040","volume":"67","author":"A Frustaci","year":"2016","unstructured":"Frustaci, A. et al. Atrogin-1 pathway activation in Cushing syndrome cardiomyopathy. J. Am. Coll. Cardiol. 67, 116\u2013117. https:\/\/doi.org\/10.1016\/j.jacc.2015.10.040 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"53913_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145047","author":"L Petramala","year":"2020","unstructured":"Petramala, L. et al. Cardiomyopathies and adrenal diseases. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21145047 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"53913_CR25","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/cvr\/cvn230","volume":"81","author":"JF Ainscough","year":"2009","unstructured":"Ainscough, J. F. et al. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. Cardiovasc. Res. 81, 592\u2013600. https:\/\/doi.org\/10.1093\/cvr\/cvn230 (2009).","journal-title":"Cardiovasc. Res."},{"key":"53913_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1210\/jc.2007-2013","volume":"93","author":"CG Patil","year":"2008","unstructured":"Patil, C. G. et al. Late recurrences of Cushing\u2019s disease after initial successful transsphenoidal surgery. J. Clin. Endocrinol. Metab. 93, 358\u2013362. https:\/\/doi.org\/10.1210\/jc.2007-2013 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1210\/jcem.76.2.8432771","volume":"76","author":"GC Toms","year":"1993","unstructured":"Toms, G. C. et al. Predicting relapse after transsphenoidal surgery for Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 76, 291\u2013294. https:\/\/doi.org\/10.1210\/jcem.76.2.8432771 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR28","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s11102-022-01226-y","volume":"25","author":"M Balomenaki","year":"2022","unstructured":"Balomenaki, M., Vassiliadi, D. A. & Tsagarakis, S. Cushing\u2019s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation. Pituitary 25, 718\u2013721. https:\/\/doi.org\/10.1007\/s11102-022-01226-y (2022).","journal-title":"Pituitary"},{"key":"53913_CR29","doi-asserted-by":"publisher","first-page":"101382","DOI":"10.1016\/j.beem.2020.101382","volume":"34","author":"O Ragnarsson","year":"2020","unstructured":"Ragnarsson, O. Cushing\u2019s syndrome\u2014disease monitoring: Recurrence, surveillance with biomarkers or imaging studies. Best Pract. Res. Clin. Endocrinol. Metab. 34, 101382. https:\/\/doi.org\/10.1016\/j.beem.2020.101382 (2020).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"53913_CR30","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1210\/jc.2008-1171","volume":"93","author":"CA Carrasco","year":"2008","unstructured":"Carrasco, C. A. et al. Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing\u2019s disease. J. Clin. Endocrinol. Metab. 93, 4728\u20134734. https:\/\/doi.org\/10.1210\/jc.2008-1171 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"53913_CR31","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/j.wneu.2018.07.055","volume":"119","author":"C Brichard","year":"2018","unstructured":"Brichard, C., Costa, E., Fomekong, E., Maiter, D. & Raftopoulos, C. Outcome of transsphenoidal surgery for CUSHING disease: a single-center experience over 20 years. World Neurosurg. 119, e106\u2013e117. https:\/\/doi.org\/10.1016\/j.wneu.2018.07.055 (2018).","journal-title":"World Neurosurg."},{"key":"53913_CR32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4158\/ep15922.Ra","volume":"22","author":"AM Abu Dabrh","year":"2016","unstructured":"Abu Dabrh, A. M. et al. Predictors of biochemical remission and recurrence after surgical and radiation treatments of Cushing disease: A systematic review and meta-analysis. Endocr. Pract. 22, 466\u2013475. https:\/\/doi.org\/10.4158\/ep15922.Ra (2016).","journal-title":"Endocr. Pract."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53913-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53913-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53913-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T11:10:08Z","timestamp":1708945808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-53913-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53913"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-53913-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,26]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4666"}}